tiprankstipranks
Trending News
More News >
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
Hong Kong Market

Compare Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$14.25B
99.64
381.23%
Ascletis Pharma, Inc.
HK$12.33
HK$12.49B
-44.18
311.44%
1 Buy
1 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$9.91B
-47.34
123.11%
1 Buy
0 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$62.80
HK$16.44B
-57.23
103.30%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$9.52B
-16.56
75.48%
Shandong Boan Biotechnology Company., Limited. Class H
HK$9.48
HK$5.90B
153.40
12.59%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
35.90
28.21
366.84%
HK:1672
Ascletis Pharma, Inc.
12.59
9.41
295.91%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.33
3.06
134.80%
HK:2162
Keymed Biosciences, Inc.
58.55
30.35
107.62%
HK:2171
CARsgen Therapeutics Holdings Ltd.
16.46
6.86
71.46%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
9.48
0.79
9.09%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts